Alyftrek 10-50-125 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FZQ11
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,993
Award facts
- Contract value 100% obligated
- $20,993.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,993.31 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 4, 2025, for the supply of Alyftrek 10-50-125 mg tablets in quantities of 14. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location with an ultimate completion date of September 5, 2025. This award was made without a set-aside designation, allowing the company to compete on equal footing in the federal procurement marketplace despite its small business status.
This delivery order was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC, established under the SPE2DB program, enables DLA to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables, to support medical supply needs across military health facilities worldwide. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio of contract awards with the Defense Logistics Agency, reflecting its critical role in distributing pharmaceuticals and medical supplies to Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FZQ11?
SPE2DB25FZQ11 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FZQ11 worth?
The government has obligated $20,993 on SPE2DB25FZQ11.
Is contract SPE2DB25FZQ11 an order under another contract?
Yes. SPE2DB25FZQ11 is a delivery order under SPE2DB22D9102, an indefinite delivery contract.
Was contract SPE2DB25FZQ11 competed?
The extent of competition for SPE2DB25FZQ11 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award